Skystar Bio-Pharmaceutical Co.
(Other OTC/NBB : SKBI)

( )
SKBI After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson 0.45%178.890.7%$1413.67m
PFEPfizer Inc. 1.40%51.380.9%$1340.95m
ABBVAbbVie, Inc. -0.44%154.791.9%$1186.63m
BMYBristol-Myers Squibb Co. 1.73%78.241.0%$1172.57m
MRKMerck & Co., Inc. 0.85%93.100.7%$1086.85m
LLYEli Lilly & Co. 0.70%301.481.1%$869.46m
AZNAstraZeneca Plc 1.78%65.641.0%$490.27m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 0.64%141.500.0%$430.00m
VERUVeru, Inc. 15.56%15.600.0%$382.60m
GSKGlaxoSmithKline Plc 0.78%44.720.2%$223.61m
NVSNovartis AG 0.13%87.930.2%$221.04m
HZNPHorizon Therapeutics Plc 2.29%92.905.4%$202.12m
SGENSeagen Inc. 2.81%146.555.7%$174.63m
NVONovo Nordisk A/S 3.02%106.360.1%$174.32m
CTLTCatalent, Inc. 3.17%100.772.0%$156.47m

Company Profile

Skystar Bio-Pharmaceutical Company (''Skystar''or the ''Company'') was incorporated in Nevada on September 24, 1998. Since its acquisition on November 7, 2005 of Skystar Bio-Pharmaceutical (Cayman) Holdings Co., Ltd. (''Skystar Cayman''), a Cayman Islands company, the Company has been engaged in the research, development, production, marketing, and sales of veterinary healthcare and medical care products. All current operations of the Company are in the People's Republic of China (''China'' or the ''PRC'').